‹ All Posts
Sunil Kotak

17th Oct · SEBI-Registered Analyst

ANURAS
- Q2FY26 Quarterly Result Announced for Anupam Rasayan India Ltd.

Q2FY26 Quarterly Result Announced for Anupam Rasayan India Ltd. -

ANURAS
Specialty Chemicals company Anupam Rasayan India announced Q2FY26 results Total revenue for Q2FY26 was at Rs 7,392 million as compared to Rs 2,959 million in Q2FY25; up 149% YoY. EBITDA (incl. other income) was at Rs 1,436 million in Q2FY26 as compared to Rs 824 million in Q2FY25, up 74% and this would translate into 19% EBITDA margin in this quarter. Profit After Tax was at Rs 572 million in Q2FY26 as compared to Rs 306 million in Q2FY25; up 87% YoY. Anand Desai, Managing Director, Anupam Rasayan, said, “I am delighted to share that Q2FY26 has been one of the best quarters for our company. We delivered a stellar performance with consolidated revenue from operations of Rs 739 crore, reflecting exceptional growth of 149% YoY and 51% sequentially. For H1FY26, consolidated revenue stood at Rs 1,229 crore, registering a robust 122% YoY growth. Sunil Kotak (Founder of SHUBH CONSULTANCY - SEBI Registered Research Analyst| INH000015826) Disclaimer: Investments are subject to market risk please read relevant documents before investing. Past performance will not guarantee the future results. My self/may associates do not own any stock recommended here. Me/My associates/My relatives do not have any conflict of Interest in the recommended stock. Me/My associates/My relatives have not received any compensation from the Company in last 12 months. Me/My associates/My relatives do not have holding above 1% in the stock recommended. This is for Intended Recipient only. Advisable to assume that we have recommended this one to our clients.

#WatchOutFor#StockInNews
821 likes·80 comments